Summary & Overview
Bilateral or Multiple Major Joint Procedures of Lower Extremity without MCC: Inpatient Reimbursement Overview
DRG 462 applies to bilateral or multiple major joint procedures of the lower extremity without Major Complication or Comorbidity. This Diagnosis-Related Group defines the inpatient clinical scope for reimbursement and determines a bundled Medicare payment that reflects expected resource use for these procedures.
DRG 462 Overview
DRG 462 covers bilateral or multiple major joint procedures of the lower extremity without Major Complication or Comorbidity. This includes procedures such as bilateral total hip or knee arthroplasties performed during the same inpatient stay when no Major Complication or Comorbidity is coded. It matters for Medicare payment because cases assigned to this Diagnosis-Related Group receive a specific inpatient reimbursement rate that reflects the expected resource use for multiple major lower-extremity joint surgeries without higher-severity complications.
Clinical Trials
- Comparative effectiveness trials of different surgical approaches and perioperative care protocols for bilateral or multiple major lower-extremity joint replacements: studies compare approaches such as staged versus simultaneous bilateral procedures, variations in anesthesia and multimodal analgesia, and standardized blood management protocols. These trials enroll patients undergoing two or more major joint replacements (hip and/or knee) during the same hospitalization or in closely timed stages to determine impacts on length of stay, transfusion needs, intraoperative complications, and early functional recovery. Results inform surgeons, hospital administrators, and payers about which strategies reduce resource use, lower complication rates, and optimize inpatient costs for this high-acuity DRG population.
- Comparative effectiveness and device-performance studies focusing on implant selection and fixation strategies in multiple joint arthroplasty patients: research evaluates outcomes for differing implant types (cemented vs cementless fixation, bearing surfaces, modularity) and fixation techniques when multiple major joints are replaced during one episode of care. These studies target older adults with advanced osteoarthritis, inflammatory arthropathies, or complex deformities who often have higher comorbidity burdens and are at increased risk for perioperative complications; endpoints include revision risk, early prosthetic complications, and short-term functional milestones. Findings are relevant to clinicians and payers because implant choice and durability affect readmission rates, need for early reoperations, and overall episode-of-care costs for DRG 462 admissions.
- Post-discharge outcomes and care-pathway research assessing rehabilitation models, transitional care, and readmission prevention after bilateral/multiple lower-extremity joint procedures: studies compare inpatient rehabilitation versus home-based physical therapy, enhanced discharge planning, and remote monitoring programs to measure functional recovery, rates of return to baseline mobility, and 30- to 90-day readmissions. The patient population includes medically complex older adults and those with limited social support who undergo multiple joint procedures and face greater challenges in mobilization and wound care. This research is critical to providers and payers because optimized post-discharge pathways can shorten total episode duration, reduce complications and avoidable readmissions, and improve value for this resource-intensive DRG.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.